Q3 2016 13F Holders as of 9/30/2016
-
Type / Class
-
Equity / Common Stock par value $0.012 per share
-
Shares outstanding
-
41M
-
Number of holders
-
20
-
Total 13F shares, excl. options
-
181K
-
Shares change
-
-31.8K
-
Total reported value, excl. options
-
$1.31M
-
Value change
-
-$252K
-
Put/Call ratio
-
0
-
Number of buys
-
5
-
Number of sells
-
-8
-
Price
-
$7.26
Significant Holders of ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) as of Q3 2016
25 filings reported holding ORMP - ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share as of Q3 2016.
ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 181K shares
of 41M outstanding shares and own 0.44% of the company stock.
Largest 10 shareholders include TOCQUEVILLE ASSET MANAGEMENT L.P. (70K shares), BARCLAYS PLC (29.9K shares), PNC Financial Services Group, Inc. (21.2K shares), MORGAN STANLEY (16K shares), Acrospire Investment Management LLC (8.36K shares), WELLS FARGO & COMPANY/MN (8K shares), DEUTSCHE BANK AG\ (5.01K shares), FineMark National Bank & Trust (3.47K shares), SIMPLEX TRADING, LLC (2.67K shares), and Penserra Capital Management LLC (2.54K shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.